SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-14-000771
Filing Date
2014-03-14
Accepted
2014-03-14 15:38:30
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imuc-10k_20131231.htm 10-K 3225259
2 EXHIBIT 10.49 imuc-ex10_20131231120.htm EX-10 277575
3 EXHIBIT 23.1 imuc-ex23_20131231400.htm EX-23 3477
4 EXHIBIT 31.1 imuc-ex31_20131231141.htm EX-31 17100
5 EXHIBIT 31.2 imuc-ex31_20131231142.htm EX-31 16621
6 EXHIBIT 32.1 imuc-ex32_20131231144.htm EX-32 8200
7 EXHIBIT 32.2 imuc-ex32_20131231143.htm EX-32 8163
8 GRAPHIC g20140313220235015363.jpg GRAPHIC 35340
  Complete submission text file 0001564590-14-000771.txt   11757918

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT imuc-20131231.xml EX-101.INS 1365148
10 XBRL TAXONOMY EXTENSION SCHEMA imuc-20131231.xsd EX-101.SCH 72902
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20131231_cal.xml EX-101.CAL 41265
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20131231_def.xml EX-101.DEF 307303
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20131231_lab.xml EX-101.LAB 456739
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20131231_pre.xml EX-101.PRE 357668
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35560 | Film No.: 14694355
SIC: 2834 Pharmaceutical Preparations